Polycystic ovary syndrome

Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Polycystic ovary syndrome.php on line 2
Polycystic ovary syndrome

LE WE PMID CA

Polycystic ovary syndrome

2244

Polyzystisches Ovar Syndrom

Adrenal gland (Diseases)

Adrenarche

AMH

Apparent cortisone reductase deficiency

Apparent DHEA sulphotransferase deficiency

Cardiovascular risk

Clomiphene citrate

Congenital adrenal hyperplasia

Cushing s syndrome

DHEA

DHEAS

Drospirenone

Hyperthecosis

Infertility

Insulin (resistance)

Metabolic syndrome

Metformin

Ovary (Cyst)

Ovary (Neoplasia)

Ovulation induction

Polycystic ovary syndrome

Sleep apnea (obstructive)

1976 1	Polycystic ovary syndrome. [788846] Br Med J 2(6038): 737-40 (1976)
2005 2	Insulin resistance in polycystic ovarian disease. [16217983] South Med J 98(9): 903-10; quiz 911-2, 923 (2005)
2004 3	Polycystic ovarian syndrome: diagnosis and management. [15931331] Clin Med Res 2(1): 13-27 (2004)
2005 4	Clinical features, investigations and management of adolescents with polycystic ovary syndrome. [19668673] Paediatr Child Health 10(10): 602-8 (2005)
2003 5	Polycystic ovary syndrome: pathogenesis and treatment over the short and long term. [12549723] Cleve Clin J Med 70(1): 31-3, 36-41, 45 (2003)
2009 6	Genetics of polycystic ovary syndrome. [20011085] Hippokratia 13(4): 216-23 (2009)
2007 7	Cardiometabolic aspects of polycystic ovarian syndrome. [17583175] Vasc Health Risk Manag 3(1): 55-63 (2007)
2008 8	Use of ethinylestradiol/drospirenone combination in patients with the polycystic ovary syndrome. [18728832] Ther Clin Risk Manag 4(2): 487-92 (2008)
2002 9	Polycystic ovaries. [11806952] Br J Radiol 75(889): 9-16 (2002)
2009 10	Polycystic ovary syndrome: a model of combinatorial endocrinology? [19584198] J Clin Endocrinol Metab 94(7): 2250-1 (2009)
2008 11	Fetal programming of adrenal androgen excess: lessons from a nonhuman primate model of polycystic ovary syndrome. [18493139] Endocr Dev 13(-): 145-58 (2008)
2011 12	Premature adrenarche: novel lessons from early onset androgen excess. [21622478] Eur J Endocrinol 165(2): 189-207 (2011)
2010 13	Metformin: an old medication of new fashion: evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome. [19841045] Eur J Endocrinol 162(2): 193-212 (2010)
2010 14	Investigation of patients with atypical or severe hyperandrogenaemia including androgen-secreting ovarian teratoma. [19906851] Eur J Endocrinol 162(2): 213-20 (2010)
2003 15	Insulin-lowering agents in the management of polycystic ovary syndrome. [14570747] Endocr Rev 24(5): 633-67 (2003)
2009 16	Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review. [19056992] Endocr Rev 30(1): 1-50 (2009)
2000 17	The importance of diagnosing the polycystic ovary syndrome. [10858183] Ann Intern Med 132(12): 989-93 (2000)
2003 18	Diabetes issues in women and children: polycystic ovary syndrome. [12882878] Diabetes Care 26(8): 2457-63 (2003)
2006 19	Insulin-sensitizing agents in polycystic ovary syndrome. [16728533] Eur J Endocrinol 154(6): 763-75 (2006)
2004 20	Screening for and treatment of polycystic ovary syndrome in teenagers. [15096648] Exp Biol Med (Maywood) 229(5): 369-77 (2004)
2009 21	Polycystic ovary syndrome, inflammation, and statins: do we have the right target? [19126632] J Clin Endocrinol Metab 94(1): 35-7 (2009)
2008 22	Impact of metformin, oral contraceptives, and lifestyle modification on polycystic ovary syndrome in obese adolescent women: do we need a new drug? [18987279] J Clin Endocrinol Metab 93(11): 4218-20 (2008)
2008 23	Polycystic ovarian syndrome, biomarkers, and metformin: research, risk, and reality. [18178908] J Clin Endocrinol Metab 93(1): 34-6 (2008)
2007 24	Glucose intolerance in polycystic ovary syndrome--a position statement of the Androgen Excess Society. [18056778] J Clin Endocrinol Metab 92(12): 4546-56 (2007)
2007 25	Clinical review: Hyperandrogenism and polycystic ovary syndrome in women with type 1 diabetes mellitus. [17284617] J Clin Endocrinol Metab 92(4): 1209-16 (2007)
2007 26	Clinical review: Identifying children at risk for polycystic ovary syndrome. [17179197] J Clin Endocrinol Metab 92(3): 787-96 (2007)
2006 27	Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. [16940456] J Clin Endocrinol Metab 91(11): 4237-45 (2006)
2006 28	Review: fetal programming of polycystic ovary syndrome by androgen excess: evidence from experimental, clinical, and genetic association studies. [16522691] J Clin Endocrinol Metab 91(5): 1660-6 (2006)
2006 29	Nonalcoholic steatohepatitis and nonalcoholic Fatty liver disease in young women with polycystic ovary syndrome. [16492691] J Clin Endocrinol Metab 91(5): 1741-7 (2006)
2006 30	Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature. [16418211] J Clin Endocrinol Metab 91(3): 781-5 (2006)
2006 31	Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: in defense of the Rotterdam criteria. [16418209] J Clin Endocrinol Metab 91(3): 786-9 (2006)
2006 32	Serum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome. [16368745] J Clin Endocrinol Metab 91(3): 941-5 (2006)
2006 33	Commentary: polycystic ovary syndrome: a syndrome of ovarian hypersensitivity to insulin? [16263814] J Clin Endocrinol Metab 91(1): 22-4 (2006)
2005 34	Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. [15623819] J Clin Endocrinol Metab 90(4): 1929-35 (2005)
2004 35	Editorial: Metformin--comparison with other therapies in ovulation induction in polycystic ovary syndrome. [15472165] J Clin Endocrinol Metab 89(10): 4797-800 (2004)
2003 36	Minimal response of circulating lipids in women with polycystic ovary syndrome to improvement in insulin sensitivity with troglitazone. [14602740] J Clin Endocrinol Metab 88(11): 5137-44 (2003)
2000 37	Metabolic lessons from the study of young adolescents with polycystic ovary syndrome--is insulin, indeed, the culprit? [11061494] J Clin Endocrinol Metab 85(10): 3520-5 (2000)
1999 38	Polycystic ovary syndrome (PCOS): arguably the most common endocrinopathy is associated with significant morbidity in women. [10372683] J Clin Endocrinol Metab 84(6): 1897-9 (1999)
1998 39	Development of a health-related quality-of-life questionnaire (PCOSQ) for women with polycystic ovary syndrome (PCOS). [9626128] J Clin Endocrinol Metab 83(6): 1976-87 (1998)
1992 40	ACP Broadsheet 131: March 1992. Hirsute women: should they be investigated? [1556225] J Clin Pathol 45(3): 188-92 (1992)
2002 41	Developmental origin of polycystic ovary syndrome - a hypothesis. [12098657] J Endocrinol 174(1): 1-5 (2002)
2008 42	Present status of understanding on the genetic etiology of polycystic ovary syndrome. [18480528] J Postgrad Med 54(2): 115-25 (2008)
2004 43	Insulin resistance, insulin sensitization and inflammation in polycystic ovarian syndrome. [15235215] J Postgrad Med 50(2): 140-4 (2004)
1999 44	Molecular mysteries of polycystic ovary syndrome. [10379878] Mol Endocrinol 13(6): 800-5 (1999)
2005 45	The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome. [15561799] Endocr Rev 26(2): 251-82 (2005)
2003 46	Metformin in polycystic ovary syndrome: systematic review and meta-analysis. [14576245] BMJ 327(7421): 951-3 (2003)
2010 47	Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. [20375205] J Clin Endocrinol Metab 95(5): 2038-49 (2010)
2004 48	Insulin resistance syndrome in children. [15181020] J Clin Endocrinol Metab 89(6): 2526-39 (2004)
2002 49	Long-term health consequences of PCOS. [12078834] Hum Reprod Update 8(3): 231-41 (2002)
2004 50	The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest. [15073141] Hum Reprod Update 10(2): 107-17 (2004)
2007 51	The role of metformin in polycystic ovary syndrome: a systematic review. [17767003] Hum Reprod Update 13(6): 527-37 (2007)
2009 52	Adiponectin levels in women with polycystic ovary syndrome: a systematic review and a meta-analysis. [19261627] Hum Reprod Update 15(3): 297-307 (2009)
2007 53	Why does ovarian surgery in PCOS help? Insight into the endocrine implications of ovarian surgery for ovulation induction in polycystic ovary syndrome. [17208949] Hum Reprod Update 13(3): 249-64 (2007)
2005 54	Combined oral contraceptives in the treatment of polycystic ovary syndrome. [15790599] Hum Reprod Update 11(3): 277-91 (2005)
2005 55	Insulin-sensitizing agents: use in pregnancy and as therapy in polycystic ovary syndrome. [15878899] Hum Reprod Update 11(4): 375-90 (2005)
2009 56	Metabolic syndrome and polycystic ovary syndrome... and vice versa. [19466215] Arq Bras Endocrinol Metabol 53(2): 227-37 (2009)
2004 57	4: Polycystic ovary syndrome. [14748678] Med J Aust 180(3): 132-7 (2004)
2007 58	Polycystic ovary syndrome and abnormal glucose tolerance. [17874976] Med J Aust 187(6): 324-5 (2007)
2007 59	Glucose tolerance abnormalities in Australian women with polycystic ovary syndrome. [17874978] Med J Aust 187(6): 328-31 (2007)
2009 60	PCOS. [19445767] Clin Evid (Online) 2009(-): - (2009)
2007 61	A 27-year-old woman with a diagnosis of polycystic ovary syndrome. [17284701] JAMA 297(5): 509-19 (2007)
2009 62	Polycystic ovarian syndrome: a misnomer for an enigmatic disease. [19479676] Ultrasound Obstet Gynecol 33(6): 621-7 (2009)
2002 63	Glucose tolerance, insulin secretion and insulin sensitivity in polycystic ovary syndrome. [11884761] JOP 3(1): 1-7 (2002)
2010 64	Anti-Müllerian hormone and polycystic ovary syndrome: a mountain too high? [20207725] Reproduction 139(5): 825-33 (2010)
2010 65	Mediators of inflammation in polycystic ovary syndrome in relation to adiposity. [20396393] Mediators Inflamm 2010(-): 758656 (2010)
2004 66	Polycystic ovary syndrome in adolescence--a therapeutic conundrum. [15016769] Hum Reprod 19(5): 1039-42 (2004)
2009 67	Androgen circle of polycystic ovary syndrome. [19279033] Hum Reprod 24(7): 1548-55 (2009)
2007 68	Metformin versus oral contraceptive pill in polycystic ovary syndrome: a Cochrane review. [17261574] Hum Reprod 22(5): 1200-9 (2007)
2008 69	Consensus on infertility treatment related to polycystic ovary syndrome. [18308833] Hum Reprod 23(3): 462-77 (2008)
2005 70	Clomiphene citrate--end of an era? A mini-review. [15878925] Hum Reprod 20(8): 2043-51 (2005)
2006 71	A systematic review and meta-analysis of randomized controlled trials on metformin co-administration during gonadotrophin ovulation induction or IVF in women with polycystic ovary syndrome. [16449310] Hum Reprod 21(6): 1387-99 (2006)
2003 72	The management of infertility associated with polycystic ovary syndrome. [14617367] Reprod Biol Endocrinol 1(-): 109 (2003)
2009 73	Polycystic ovary syndrome: a major unrecognized cardiovascular risk factor in women. [20111659] Rev Obstet Gynecol 2(4): 232-9 (2009)
2007 74	Polycystic ovary syndrome and its developmental origins. [17659447] Rev Endocr Metab Disord 8(2): 127-41 (2007)
2011 75	Treatment options for polycystic ovary syndrome. [21339935] Int J Womens Health 3(-): 25-35 (2011)
2010 76	Obstructive sleep apnea and metabolic dysfunction in polycystic ovary syndrome. [21112021] Best Pract Res Clin Endocrinol Metab 24(5): 717-30 (2010)
2009 77	Evaluation of adolescents for polycystic ovary syndrome in an urban population. [21274294] J Clin Res Pediatr Endocrinol 1(4): 188-93 (2009)
2010 78	Insulin resistance, obesity, inflammation, and depression in polycystic ovary syndrome: biobehavioral mechanisms and interventions. [20471009] Fertil Steril 94(5): 1565-74 (2010)
2011 79	State of the Art Review: Emerging Therapies: The Use of Insulin Sensitizers in the Treatment of Adolescents with Polycystic Ovary Syndrome (PCOS). [21899727] Int J Pediatr Endocrinol 2011(-): 9 (2011)
2008 80	Polycystic ovary syndrome and oocyte developmental competence. [18081939] Obstet Gynecol Surv 63(1): 39-48 (2008)
2010 81	Polycystic ovary syndrome in the pediatric population. [20939704] Metab Syndr Relat Disord 8(5): 375-94 (2010)
2009 82	Long-term effect of metformin on metabolic parameters in the polycystic ovary syndrome. [20368201] Diab Vasc Dis Res 6(2): 110-9 (2009)
2005 83	Polycystic ovary syndrome. Revised diagnostic criteria and long-term health consequences. [16613823] Hormones (Athens) 4(3): 133-47 (2005)
2006 84	The use of insulin sensitising agents in ovulation induction in women with polycystic ovary syndrome. [16950750] Hormones (Athens) 5(3): 171-8 (2006)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Polycystic ovary syndrome.php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Polycystic ovary syndrome.php on line 92